These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7851075)
1. Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden. Clauson P; Linnarsson R; Gottsäter A; Sundkvist G; Grill V Diabet Med; 1994 Oct; 11(8):794-801. PubMed ID: 7851075 [TBL] [Abstract][Full Text] [Related]
2. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Borg H; Gottsäter A; Fernlund P; Sundkvist G Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset. Rattarasarn C; Diosdado MA Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726 [TBL] [Abstract][Full Text] [Related]
4. Is type 2 diabetes a different disease in obese and nonobese patients? Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730 [TBL] [Abstract][Full Text] [Related]
5. Relationships between beta-cell function and diabetic duration and albuminuria in type 2 diabetes mellitus. Shin SJ; Lee YJ; Hsaio PJ; Chen JH; Guh JY; Chen MT; Chen WC; Tsai JH Pancreas; 1997 Mar; 14(2):192-8. PubMed ID: 9057193 [TBL] [Abstract][Full Text] [Related]
6. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents. Colman PG; Harrison LC; Tait BD Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215 [TBL] [Abstract][Full Text] [Related]
7. Metabolic risk profiles in diabetes stratified according to age at onset, islet autoimmunity and fasting C-peptide. Wod M; Yderstræde KB; Halekoh U; Beck-Nielsen H; Højlund K Diabetes Res Clin Pract; 2017 Dec; 134():62-71. PubMed ID: 28987750 [TBL] [Abstract][Full Text] [Related]
8. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity. Hosker JP; Kumar S; Gordon C; Bhatnagar D; France M; Boulton AJ Diabet Med; 1993 Jul; 10(6):509-13. PubMed ID: 8365085 [TBL] [Abstract][Full Text] [Related]
9. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus. Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity. Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266 [TBL] [Abstract][Full Text] [Related]
11. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
12. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790 [TBL] [Abstract][Full Text] [Related]
13. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology. Bruno G; De Salvia A; Arcari R; Borra M; Grosso N; Carta Q; Trovati M; Veglio M; Pagano G Diabetes Care; 1999 Jan; 22(1):50-5. PubMed ID: 10333903 [TBL] [Abstract][Full Text] [Related]
14. Relationship between autonomic cardiac activity, beta-cell function, anthropometrics and metabolic indices in type II diabetics. Manzella D; Carbonella M; Ragno E; Passariello N; Grella R; Paolisso G Clin Endocrinol (Oxf); 2002 Aug; 57(2):259-64. PubMed ID: 12153606 [TBL] [Abstract][Full Text] [Related]
15. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
16. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745 [TBL] [Abstract][Full Text] [Related]
17. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [TBL] [Abstract][Full Text] [Related]
18. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054 [TBL] [Abstract][Full Text] [Related]
19. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance]. Zeng CJ; Zhang L; Yang HX Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544 [TBL] [Abstract][Full Text] [Related]
20. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]